DOI : https://doi.org/10.18517/ijaseit.11.2.12955

Gradient Boosting Machine Based on PSO for prediction of Leukemia after a Breast Cancer Diagnosis

Mohanad A. Deif (1), Rania E. Hammam (2), Ahmed A. A. Solyman (3)
(1) Department of Bioelectronics, Faculty of Engineering, Modern University of Technology and Information (MTI) University, Egypt
(2) Department of Bioelectronics, Faculty of Engineering, Modern University of Technology and Information (MTI) University, Egypt
(3) Department of Electrical and Electronics Engineering, Istanbul Gelisim University, Turkey
Fulltext View | Download
How to cite (IJASEIT) :
A. Deif, Mohanad, et al. “Gradient Boosting Machine Based on PSO for Prediction of Leukemia After a Breast Cancer Diagnosis”. International Journal on Advanced Science, Engineering and Information Technology, vol. 11, no. 2, Apr. 2021, pp. 508-15, doi:10.18517/ijaseit.11.2.12955.
Citation Format :
The purpose of this study is to develop an accurate risk predictive model for Chronic Myeloid Leukemia (CML) after an early diagnosis of Breast Cancer (BC). Gradient Boosting Machine (GBM) classification algorithm has been applied to the SEER breast cancer dataset for females diagnosed with BC from 2010 to 2016. A practical Swarm optimizer (PSO) was utilized to optimize the GBM algorithm's hyperparameters to find the SEER dataset's best attributes. Nine attributes were carefully selected to study the growth of CML after a lag time of 6 months following BC's diagnosis. The results revealed that the predictive model could classify patients with breast cancer only and patients with breast cancer with Leukemia by an achieved Accuracy, Sensitivity, and Speciï¬city rates of 98.5 %, 99 %, 97.85 %, respectively. To verify the performance of the proposed algorithm, the accuracy of the suggested GBM classifier model was compared with another state-of-the-art model classifiers KNN (k-Nearest Neighbor), SVM (Support Vector Machine), and RF (Random Forest), which are commonly applied algorithms in most of the existing literature. The results also proved the superior ability of the implemented GBM model Classifier in the classification of breast cancer disease and prediction of patients having Leukemia developed after having breast cancer. These results are promising as they show the integral role of the GBM classifier to classify and predict the tumor with high accuracy and efficiency, which will further help in better cancer diagnosis and treatment of the disease.

R. Shenolikar, E. Durden, N. Meyer, G. Lenhart, and K. Moore, “Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States,” Gynecol. Oncol., vol. 151, no. 2, pp. 190-195, 2018.

I. Vanidassane, A. Gogia, V. Raina, and R. Gupta, “Treatment Related Acute Myeloid Leukemia in Breast Cancer Survivors: A Single Institutional Experience,” Indian J. Hematol. Blood Transfus., vol. 35, no. 3, pp. 561-562, 2019.

A. Matikas et al., “Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer,” Breast Cancer Res. Treat., vol. 168, no. 2, pp. 349-355, 2018.

H. Choi et al., “A Case of Preleukemic Chronic Myeloid Leukemia Following Chemotherapy and Autologous Transplantation for T-lymphoblastic Lymphoma.,” Ann. Lab. Med., vol. 40, no. 5, pp. 417-420, 2020.

I. Lalya, I. Essadi, R. Belbaraka, A. El Omrani, and M. Khouchani, “Acute Myeloid Leukemia After Treatment of Early Breast Cancer: Case Report and Literature Review,” Indian J. Gynecol. Oncol., vol. 17, no. 3, p. 60, 2019.

T. Radivoyevitch et al., “Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma,” Leuk. Res., vol. 74, pp. 130-136, 2018.

M. Payandeh, R. Khodarahmi, M. Sadeghi, and E. Sadeghi, “Appearance of acute myelogenous leukemia (AML) in a patient with breast cancer after adjuvant chemotherapy: case report and review of the literature,” Iran. J. cancer Prev., vol. 8, no. 2, p. 125, 2015.

A. Balduzzi and M. Castiglione-Gertsch, “Leukemia risk after adjuvant treatment of early breast cancer,” Women’s Heal., vol. 1, no. 1, pp. 73-85, 2005.

M. J. Al-Husseini et al., “Risk and survival of chronic myeloid leukemia after breast cancer: A population-based study,” Curr. Probl. Cancer, vol. 43, no. 3, pp. 213-221, 2019.

S. V. Ezhilraman, S. Srinivasan, and G. Suseendran, “Breast Cancer Detection using Gradient Boost Ensemble Decision Tree Classifier.”

T. Mitchell and M. L. McGraw-Hill, “Edition.” New York: McGraw-Hill, Inc, 1997.

S. Makridakis, E. Spiliotis, and V. Assimakopoulos, “Statistical and Machine Learning forecasting methods: Concerns and ways forward,” PLoS One, vol. 13, no. 3, p. e0194889, 2018.

Y. D. Austria, P. L. Jay-ar, L. B. S. Maria Jr, J. E. E. Goh, M. L. I. Goh, and H. N. Vicente, “Comparison of Machine Learning Algorithms in Breast Cancer Prediction using the Coimbra Dataset,” Cancer, vol. 7, p. 10, 2019.

H. G. Kaplan, G. S. Calip, and J. A. Malmgren, “Maximizing Breast Cancer Therapy with Awareness of Potential Treatment”Related Blood Disorders,” Oncologist, vol. 25, no. 5, p. 391, 2020.

H. Chen, L. Cui, Q. Guo, and J. Zhang, “Improved Particle Swarm Optimization Using Wolf Pack Search,” in Journal of Physics: Conference Series, 2019, vol. 1176, no. 5, p. 5, 2009.

A.-A. RATES and A.-S. RATES, “SEER cancer statistics review 1975-2005,” 2008.

S. I. Abed, “Predicting Breast Cancer Using Gradient Boosting Machine,” vol. 8, no. 6, pp. 885-891, 2019.

A. Talele, A. Patil, and B. Barse, “Detection of Real Time Objects Using TensorFlow and OpenCV,” Asian J. Converg. Technol., 2019.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).